Hero Image

Prostate Cancer Symptoms, Testing and Treatment Guide

Prostate cancer is one of the most common cancers in men, and catching it early can save lives.

Understanding symptoms, testing, and modern treatment choices helps you make clear, confident decisions with your care team.

Early symptoms and when to see a urologist

In its earliest stages, prostate cancer often causes few or no warning signs. Still, there are several early signs not to ignore that can point to a problem. For a quick refresher on common signs, see the American Cancer Society’s overview of prostate cancer symptoms.

  • Difficulty starting or stopping urine
  • Weak or interrupted urine flow; frequent nighttime urination
  • Blood in urine or semen
  • Persistent pain or stiffness in the lower back, hips, or pelvis
  • Erectile dysfunction or discomfort during ejaculation

Red flags that can signal more advanced disease include unexplained weight loss, new numbness or weakness in the legs, or new bone pain—if you notice these, contact your doctor promptly and review the National Cancer Institute (NCI) basics on prostate cancer. If symptoms persist, schedule a urologist visit. A focused evaluation may include a PSA blood test and, in some cases, a digital rectal exam (DRE). Learn more about screening conversations from the USPSTF prostate cancer screening recommendation and patient-friendly PSA information from the Urology Care Foundation.

Making sense of Gleason score and risk groups

After diagnosis, your pathology report typically includes a Gleason score (now commonly reported as Grade Group 1–5).

Lower numbers usually mean slower-growing cancer; higher numbers indicate more aggressive disease—see the NCI definition of the Gleason score for details.

Doctors combine your PSA, biopsy results, MRI findings, and stage to classify risk (low, intermediate, or high). This risk grouping guides whether active surveillance is reasonable or if treatment such as surgery, radiation, or systemic therapy is recommended. For a deeper dive into staging and risk, review the ACS guide on prostate cancer staging.

Comparing treatment options

Because no two cases are identical, it’s helpful to discuss options in a multidisciplinary setting with urology, radiation oncology, and (when needed) medical oncology. Below is a quick, plain-language tour of the most common paths.

Surgery (prostatectomy)

A radical prostatectomy removes the prostate gland and some surrounding tissue. Many centers offer minimally invasive or robot-assisted approaches that can reduce blood loss and shorten hospital stays. The American Cancer Society outlines what to expect with surgery, including recovery steps and potential side effects.

Men often weigh prostatectomy vs. radiation. Surgery can provide precise staging information (via the removed tissue) and, in certain cases, offers excellent long-term control. Potential side effects include urinary incontinence and erectile dysfunction; these often improve over time for many men with pelvic floor rehabilitation, medications, and devices.

Radiation therapy (IMRT, SBRT, brachytherapy, proton)

Radiation therapy treats the prostate using high-energy beams. Common techniques include IMRT (intensity-modulated radiation therapy), SBRT (stereotactic body radiation therapy), and seed implants (brachytherapy). Explore treatment types and side effects in the NCI’s overview of radiation therapy.

Some centers offer proton therapy for prostate cancer. Current evidence suggests similar cancer control to IMRT; studies continue to compare side-effect profiles. Learn more in the NCI primer on proton therapy.

Active surveillance

Active surveillance means closely monitoring low-risk disease with regular PSA tests, MRI, and periodic biopsies—delaying treatment unless signs of progression appear. Key benefits include avoiding immediate side effects of surgery or radiation; drawbacks can include anxiety and the small risk of missing a window for cure if cancer changes between checks. See the NCI’s patient guide to prostate cancer treatments (PDQ), including active surveillance.

Advanced and emerging therapies

For more aggressive or recurrent disease, systemic therapies can help:

  • Hormone therapy (androgen deprivation): Lowers testosterone to slow cancer growth. Possible long-term side effects include hot flashes, fatigue, sexual side effects, weight gain, and muscle/bone loss. Review options and risks in the ACS section on hormone therapy.
  • Targeted and radiopharmaceutical therapies: Selected for cancers with specific features (e.g., PARP inhibitors for DNA-repair defects; PSMA-targeted radioligand therapy such as lutetium-177–PSMA). Learn more in the NCI’s patient PDQ on prostate cancer treatment and this overview of PSMA-targeted therapy.
  • Immunotherapy: Options like sipuleucel‑T or checkpoint inhibitors can help some men with advanced disease—see NCI’s treatment PDQ for who may benefit.

Ask about clinical research opportunities. Clinical trials provide access to cutting‑edge therapies and help move the field forward. Search actively enrolling studies on ClinicalTrials.gov and the NCI trial finder at cancer.gov. Some trials may offer travel support or stipends; coordinators can explain eligibility, logistics, and potential costs.

Managing side effects and recognizing recurrence

Erectile dysfunction (ED) after treatment is common, particularly soon after surgery or radiation. Effective options include oral medications, vacuum erection devices, injections, counseling, and—in select cases—implants. Explore strategies in the ACS resource on sexual health after cancer.

Urinary incontinence after prostate surgery can often be improved with pelvic floor (Kegel) exercises, supervised pelvic rehabilitation, medications, or minimally invasive procedures. Helpful overviews are available from the Urology Care Foundation on urinary incontinence in men.

After definitive treatment, your team will monitor for signs of prostate cancer recurrence—most often through PSA testing and periodic exams. Know your follow-up plan and PSA goals; the ACS explains typical schedules in its guide to post-treatment follow-up.

Finding specialists and financial support

Choosing a trusted care team matters. You can browse NCI‑Designated Cancer Centers, ask your primary care clinician for referrals, or use the Urology Care Foundation’s directory to find a urologist. A dedicated patient navigator—such as those available through the American Cancer Society—can help with scheduling, education, and support.

To understand coverage, review Medicare’s cancer treatment benefits and call your insurer for plan-specific details. If costs are a concern, explore reputable resources such as CancerCare financial assistance and hospital-based patient assistance programs. Many centers also have social workers who can connect you with transportation, lodging, and copay support.

Key takeaways

  • Know the symptoms—and don’t ignore persistent changes in urination, sexual function, or pelvic pain.
  • Ask how your Gleason score/Grade Group and PSA influence risk and treatment choices.
  • Discuss prostatectomy vs. radiation, proton therapy vs. IMRT, and whether active surveillance fits your situation.
  • Plan ahead for side-effect management and stick to a clear follow-up schedule.
  • Leverage navigators, second opinions, and clinical trials to personalize care.

Bottom line

Being informed about symptoms, diagnosis, and the full range of therapies—from surveillance to advanced treatments—can help you work with your clinicians to choose the path that best matches your goals and values. For context, about 1 in 8 men will be diagnosed with prostate cancer during their lifetime—knowledge and timely action truly matter.